Some stocks are better placed than others to withstand the economic turmoil caused by Covid-19 - but is Tristel (LON:TSTL) one of them? To understand why different shares respond to chaos in different ways, it pays to look at their str...
|Type||Buy / Hold / Sell|
|Year End 30th Jun||Unit||2017||2018||2019||2020||2021||2022E||2023E||CAGR / Avg|
|Diluted Normalised EPS|
|Op. Cashflow ps|
|Free Cashflow ps|
|Diluted Weighted Average Shares||m|
|Book Value ps|
|Leverage (ttm)||Total||- Intang||+ Pension|
|Cash / Assets|
Latest News & Insights for TSTL
An important question for small-cap investors right now is whether the current uncertainty caused by Covid-19 will affect the share prices of companies like Tristel. The stock is currently trading at 600p, but to predict how the price...
Quality and momentum are highly prized among investors looking for reliable investment ideas. That's because good quality stocks tend to be resilient, cash-generating businesses that can compound investment returns over time. And those...
An important question for small-cap investors right now is whether the current uncertainty caused by Covid-19 will affect the share prices of companies like Tristel. The stock is currently trading at 596p, but to predict how the price...
Shares in Tristel (LON:TSTL) are currently trading at 650p but a key question for investors is how the economic uncertainty caused by Covid-19 will affect the price. The answer comes down to judging whether it is well placed to withsta...
Tristel plc is a United Kingdom-based manufacturer of infection prevention products. The Company’s technology is a chlorine dioxide formulation used by hospitals for the high-level disinfection of medical devices and the sporicidal disinfection of environmental surfaces. The Company’s segments include Hospital medical device decontamination and Hospital environmental surface disinfection. The Company manufactures and sells medical device decontamination products that are used primarily for infection control in hospitals. The Company also manufactures and sells hospital environmental surface disinfection products. The Tristel brand offers airway management, cardiology, ear, nose and throat, ophthalmology, endoscopy, phlebotomy, surfaces, ultrasound, urology, and women's health. The Crystel brand offers pharmaceutical, cosmetic and toiletry (PCT), cleanroom disinfectants and laboratory disinfectants. It markets its products under the Tristel, Anistel, and Crystel brands.
- Lynx Business Park,Fordham Road, SNAILWELL, CB8 7NY
- +44 1638721500
- KPMG LLP
Latest News for TSTL
Upcoming Events for TSTL
Q4 2022 Tristel PLC Trading Statement Release
Tristel PLC Shareholder Open Day
Full Year 2022 Tristel PLC Earnings Release
Tristel PLC Annual Shareholders Meeting
As of Today at 07:23 UTC, shares in Tristel are trading at 342.50p. This share price information is delayed by 15 minutes.
Shares in Tristel last closed at 342.50p and the price had moved by -47.06% over the past 365 days. In terms of relative price strength the Tristel share price has underperformed the FTSE All Share Index by -44.7% over the past year.
The overall consensus recommendation for Tristel is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Tristel dividend yield is 1.91% based on the trailing twelve month period.
Last year, Tristel paid a total dividend of £0.07, and it currently has a trailing dividend yield of 1.91%. We do not have any data on when Tristel is to next pay dividends.
We do not have data on when Tristel is to next pay dividends. The historic dividend yield on Tristel shares is currently 1.91%.
To buy shares in Tristel you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 342.50p, shares in Tristel had a market capitalisation of £161.75m.
Here are the trading details for Tristel:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: TSTL
Based on an overall assessment of its quality, value and momentum Tristel is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Tristel is 442.50p. That is 29.2% above the last closing price of 342.50p.
Analysts covering Tristel currently have a consensus Earnings Per Share (EPS) forecast of £0.07 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Tristel. Over the past six months, its share price has underperformed the FTSE All Share Index by -13.55%.
As of the last closing price of 342.50p, shares in Tristel were trading -16.38% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Tristel PE ratio based on its reported earnings over the past 12 months is 42.55. The shares last closed at 342.50p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Tristel's management team is headed by:
- Bruno Holthof - NEC
- Paul Swinney - CEO
- Elizabeth Dixon - CFO
- Bart Leemans - EDR
- David Orr - NED
- Tom Jenkins - NID
- Isabel Napper - NID
- Caroline Stephens - NID